Skip to main content
OpenTrials
Completed

NCT Number: NCT03622320

Metabolic Syndrome in Early Onset Versus Late Onset Vitiligo

This study aims at detection of possible associated metabolic syndrome with vitiligo and assessment of possible contribution of the age of onset of vitiligo.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Cairo university hospitals, dermatology outpatient clinic

Cairo, Egypt

About this study

This study aims at detection of incidence of metabolic syndrome in vitiligo patients and possible contribution of the age of onset of the disease. This involves detection of waist circumference, body mass index, index of central obesity, systolic and diastolic arterial blood pressure, fasting blood sugar, high density lipoproteins and triglycerides, in addition to insulin resistance as Homeostatic Model Assessment- insulin resisitance (HOMA-IR) and serum leptin in vitiligo patients. The outcomes will be correlated to extent/ severity/duration/ activity of vitiligo as well as to the age of onset. This is assumed to be of profound impact on vitiligo patients by properly assessing these patients for associated metabolic risk factors and helping prevent such metabolic derangements by detection of possible contributing factors such as insulin resistance and high serum adipokines as leptin.

Since there is temporal relation between nutrition, metabolic derangements and skin diseases where nutritional deficiencies as minerals, vitamins and fatty acids can lead to cutaneous manifestations and , on the other hand; skin diseases could contribute to metabolic derangements and nutritional deficiencies, the investigator's study will focus on nutrition and dietary habits and there possible contribution to any associated metabolic risk in vitiligo patients.

This is likely to open new horizons in the management of vitiligo, possibly through control of metabolic syndrome risk factors and insulin resistance as well as revealing possible temporal relation to dietary habits that are overlooked in vitiligo patients.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Both genders
  • Patients with non-segmental vitiligo (NSV) and segmental vitiligo

Exclusion criteria

  • Smoking
  • Pregnancy
  • Systemic steroid intake in the last 6 months

Treatment and study plan

blood sample

Other

Blood sample for fasting blood sugar (FBS), High density lipoproteins (HDL), Triglycerides (TG) ,HOMA-IR, serum leptin

Primary outcomes

  1. Central obesity as a Metabolic risk in vitiligo patients

    Time frame: one year

    Central obesity will be assessed using waist circumference in cm in vitiligo patients and control group as a risk factor for metabolic syndrome

Secondary outcomes

  1. Arterial Blood Pressure as a Metabolic risk in vitiligo patients

    Time frame: one year

    Arterial Blood Pressure will be assessed in vitiligo patients and control group as a risk factor for metabolic syndrome

  2. Fasting Blood pressure as a Metabolic risk in vitiligo patients

    Time frame: one year

    Fasting Blood pressure will be assessed in vitiligo patients and control group as a risk factor for metabolic syndrome

  3. Serum Triglycerides and HDL

    Time frame: one year

    Serum Triglycerides and HDL will be assessed in vitiligo patients and control group as a risk factor for metabolic syndrome

  4. Body mass index as a Metabolic risk in vitiligo patients

    Time frame: one year

    Body Mass index in kg/m2 will be assessed in vitiligo patients and control group as a risk factor for metabolic syndrome

  5. Detection of insulin resistance in patients with vitiligo

    Time frame: one year

    This is via measuring HOMA-IR

  6. Correlation between extent/ severity/duration/ activity of vitiligo and possible associated metabolic derangements.

    Time frame: one year

    This via detecting VASI, VES and VIDA scores for vitiligo patients

  7. Correlation between extent/ severity/duration/ activity of vitiligo and the age of onset.

    Time frame: one year

    This via detecting VASI, VES and VIDA scores for vitiligo patients and relating to the age of onset

  8. Detection of possible influence of dietary habits and its relation to metabolic derangements and disease progression

    Time frame: one year

    This via directly addressing dietary habits

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Aug 9, 2018
Registry last updated
Apr 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.